Minister for Foreign Affairs visits Pharmacosmos in celebration of the company’s 60th anniversary

Press Release – Holbæk, 20 June 2025

Minister for Foreign Affairs visits Pharmacosmos in celebration of the company’s 60th anniversary

Pharmacosmos is celebrating its 60th anniversary with a major gathering at its headquarters in Holbæk, bringing together employees from the company’s offices in the USA, China, the UK, Ireland, Germany and the Nordic countries. As a special recognition of the company’s impact and development, the Danish Minister for Foreign Affairs, Lars Løkke Rasmussen, also attended the celebrations.

Pharmacosmos was founded in 1965 by Henry Christensen, MD. At the time, the ambition was modest: to create something of value through curiosity, perseverance, and inventiveness. For three decades, from the early 1990s to 2022, his son, Lars Christensen, MD, led the company. Sixty years after its founding, Pharmacosmos stands as a Danish, family-owned pharmaceutical company with global reach – and has multiplied its revenue several times over since its last anniversary in 2015.

Today, from its base in Holbæk, the company delivers treatments to millions of patients across the world’s largest markets. Since 2009, the company’s iron therapy Monofer, administered intravenously, has become a cornerstone of its growth and international expansion. In recent years, Pharmacosmos has acquired two companies in the United States and entered new therapeutic areas, including treatment of chemotherapy-induced myelosuppression in patients with small cell lung cancer.

“This is a big day for us, not least because all of the company’s 700 employees are gathered in Denmark to celebrate the anniversary. We are not only proud of what we’ve achieved but of our entire organisation,” says CEO Tobias S. Christensen. “The anniversary is not just an opportunity to reflect on the past, but a chance to prepare the entire organisation for the next stage of our development.”

Addressing employees from across Pharmacosmos, Minister for Foreign Affairs Lars Løkke Rasmussen put the company’s Danish origins and capabilities into perspective. In his speech, the Minister highlighted the importance of a strong Danish life sciences sector:

“It is truly impressive how Pharmacosmos is leading the way in tackling the global anaemia problem. In Denmark, we have a strong tradition for authorities and the private sector working together – and that is a cornerstone in the Danish Government’s new Life Science strategy. Let us commit to building on this foundation, not just for ourselves but for the generations to come.”

Looking ahead, Pharmacosmos will continue to build on its core competencies in carbohydrate chemistry and cell cycle biology to develop innovative treatments for patients with limited therapeutic options – with a particular focus on iron metabolism and blood-related diseases.

About Pharmacosmos

Pharmacosmos A/S is a global leader in carbohydrate chemistry and innovative treatments for iron deficiency and iron deficiency anaemia. Building on our foundational expertise in carbohydrate chemistry and cell cycle biology, we develop innovative treatments for unmet patient needs, with a focus on iron metabolism and blood-related disorders. Founded in 1965 and headquartered in Denmark, our team is made up of more than 700 specialists across the UK, Ireland, the Nordics, Germany, the USA, and China

Christian Lundquist Madsen,

Vice President Global Marketing & Communication

+45 5948 5959 clm@pharmacosmos.com